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ON THE ROLE OF THE H-2 HISTOCOMPATIBILITY COMPLEX
IN DETERMINING THE SPECIFICITY OF
CYTOTOXIC EFFECTOR CELLS SENSITIZED AGAINST
SYNGENEIC TRINITROPHENYL-MODIFIED TARGETS*
By JAMES FORMAN
(From The University of Texas, Department of Microbiology, Southwestern Medical School,
Dallas, Texas 75233)
Interaction of spleen cells with trinitrobenzene sulfonic acid (TNBS)' results
in the generation of new antigenic determinants (NAD) on the cell surface (1).
The trinitrophenyl (TNP)-modified cells are capable of sensitizing syngeneic
spleen cells in vitro so that effector Tcells are generated that display a specific
cytotoxic effect against only TNP-modified target cells. Further, whenallogeneic
TNP-modified H-2 target cells are substituted for syngeneic targets, no
cytolysis is observed (1). Therefore, the H-2 complex plays a role in determining
the specificity of the cytotoxic effect in this syngeneic system of cell-mediated
lympholysis (CML).
There are two interpretations to explain this data . The first is that TNBS modifies H-2
antigens, or products controlled by the H-2 complex, so as to create a NAD which is
specific for the H-2-product modified. Thus, killer T cells sensitized against syngeneic
H-2k-TNP-modified stimulators will kill only H-2k-TNP targets and not H-2° TNP-modi-
fied targets since the NAD created on the two different carriers would be different. The
second interpretation is that the specificity of the T cell generated in this system is against
several TNP-modified cell surface proteins, which would suggest a wide range of
cross-reactivity against all TNP-modified target cells. However, the H-2 complex would
restrict or control specificity by requiring identity between effector and target cell at some
region of the H-2 complex in order for cell-mediated lysis to occur. This would be
analogous to the findings of Katz et al. (2), who have shown that for an optimal immune
response, T and B cells must share H-2 genes.
The data presented in this report demonstrate that the first interpretation is
correct; i.e., the specificity of the effector cell is directed against altered selfH-2
antigens. Further, theproducts modified bythe reaction with TNBS, that are the
target structures in these reactions, are not controlled by the I region of the H-2
complex, but rather by the Kregion, although minor involvement oftheDregion
cannot be excluded.
* This work was supported by U. S. Public Health Service Research Grant AI11851.
Abbreviations used in this paper: BSS, balanced salt solution ; CML, cell-mediated lymphol-
ysis; Con A, concanavalin A; FCS, fetal calfserum ; LCM, lymphocytic choroimenenigitic virus; NAD,
new antigenic determinants; PBS, phosphate-buffered saline; TNBS, trinitrobenzene sulfonic acid.
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Materials and Methods
Animals.
￿
Mice were obtained from JacksonLaboratories, BarHarbor, Maine, andmaintained in
our animal colonies at theUniversity of Texas Southwestern Medical School, Dallas, Texas. Some of
the strains used in the mappingstudies were made available through the generosity of Dr. Jan Klein,
University of Texas Southwestern Medical School.
Tumors. EL4 (H-2°) tumor cells were maintained in the ascites form by weekly passage to
C57BL/6 mice. The H-2d tumor line is maintained in vitro, and was the gift of Dr. David Grausz,
Department of Biology, University of California at San Diego, La Jolla, Calif. This tumorwas typed
serologically in our laboratory.
Isotopes.
￿
"Cr was obtained from Amersham/Searle Corp., Arlington Heights, Ill.
Radiation.
￿
Cells were irradiated with a "'Cs source at a rate of 115 rads/min.
Preparation and Labeling of Target Cells for the Cytotoxicity Assay.
￿
Mice were killed by cervical
dislocation, their spleens excised, and a cell suspension made in abalanced salt solution (BSS). After
washing, the cells were suspended at a concentration of 4.0 x 106 nucleated cells/ml in RPMI 1640
(Grand Island Biological Corp ., Grand Island, N. Y.) supplemented with 5% heat-inactivated fetal
calf serum (FCS) and 3 x 10-' M 2-mercaptoethanol . 4 ml of this suspension were added to
individual Falcon flasks (no. 3013, Falcon Plastics, Div. ofBioQuest, Oxnard, Calif.) and placed on a
rocking platform at 37°C. After 2 days, concanavalin A (Con A) (ICN Nutritional Biochemicals Div.,
International Chemical & NuclearCorp, Cleveland, Ohio) wasaddedat a concentration of 5,ug/ml. 3
days laterthecells were harvested (usually from twoflasks) andcentrifuged together in a 17 x100mm
plastic tube. The cell pellet was resuspended in 0.2 ml of RPMI 1640 with 1% FCS and 200,uCi of
["Crisodium chromate (Amersham/Searle Corp.) was added in a vol of 0.2 ml. The cells were
incubated at 37°C for 1.5 h and then washed three times in BSS. After the third wash, the cells were
resuspended in 1.0 ml of phosphate-buffered saline (PBS) or PBS containing 1.0 mM of TNBS
(Eastman Organic ChemicalsDiv., Eastman Kodak Co., Rochester, N.Y.) andplaced at 37°C for10
min. The cells were then washed twicein BSS containing 10% FCS, andincubatedfor 1.5 hat 37°C in
RPMI with FCS. The cells were washed twice more and adjusted to a concentration of 106 viable
cells/ml. 0.1 ml of this target cell suspension was addedto Petri dishes containing the effector cells.
Tumor cells were labeled by harvesting the cells from either animals or flasks, washing them two
times in BSS, and then incubating 5 x 106 cells with 5'Cr in RPMI 1640 as described above forthe
Con A lymphoblasts.
Generation of Effector Cells for the CML Assay.
￿
Effector cells were generated by coculturing
responder cells along with stimulator cells in 35 mm plastic Petri dishes in the same media as
described forthe culture of target cells. 5million responder cells were added in atotalvol of 1.0 ml to
each dish along with 1 x 106 stimulator cells in a vol of 0.1 ml, and each group consisted of three
replicates. The cellswere cultured in a CO, atmosphere for5days as previously described (3), and at
this time 10' target cells in avolof 0.1 ml were then added to the dishes to assayfor cytotoxicactivity.
After 4 h, the contents of thedishes were harvested with a plasticpolicemanand transferred to 12 x 75
mm tubes, centrifuged, and half of the supernatant was removed.
Data Processing.
￿
The formula used to calculate percent release of isotope is:
%release "Cr =
￿
(cpm supernate - bk) x 2
￿
x 100,
(cpm supernate + pellet) - 2 x bk.
where bk is background in counts per minute.
Inhibition assay of CML activity.
￿
Con A lymphoblasts were prepared in the same manner as the
target cellsfortheCML assay except that they were not labeled with "Cr. The cells were adjusted to
10 times the concentration required for theassay and 0.1-ml volof these inhibitors were addedto the
effector cell mixtures at the same time as the target cells.
Modification of Stimulator Cells with TNBS. To modify the stimulator cells with TNBS,
approximately 30 x 106spleen cellswere incubatedin PBScontaining 1.0 mM TNBS. After10 min at
37°C, thecellswere washed twicein BSS containing 10%FCSand then adjusted to aconcentration of
10 x 106 cells/ml. 0.1 ml of this suspension was added to individual Petri dishes as the source of
stimulator cells.JAMES FORMAN
￿
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Results
Ability of TNP-Sensitized Spleen Cells to Generate aSpecific Cytotoxic Effect
against TNP-Modified Target Cells of Different H-2 Haplotypes. Shearer (1)
reported that TNP-modified cells sensitize syngeneic splenic T cells so that they
display a specific cytotoxic effect against only H-2-compatible TNP-modified
target cells. The experimental data presented in Table I confirm these results.
Thus, B10.A (H-2°) cells sensitized to B10.A TNP-modified stimulators are
TABLE I
Specificity of Sensitized Effector Cells against TNP-Modified Targets of a Different
H-2 Haplotype
*Net release, % "Cr release from target cells in the presence of effector cells sensitized to
TNP-modified stimulators - % "Cr release from target cells in the presence of effector cells
sensitized to unmodified stimulators (nonimmune).
Line
Responder
(genotype) Stimulator Target "Crrelease
t SEM
Net
release
1 1310.A (H-2°) B10.A B10.A 40.8 t 2.2
B10.A (H-2°) B10.A-TNP B10.A 38.7 -±:3.4 -2.1
2 1310.A 1310 .A B10.A-TNP 39.8 f 1.9 35.7
1310.A B10.A-TNP 1310.A-TNP 75.5 -+:4.8
3 1310.A B10.A B10-TNP 36.1 t 3.4
1310.A B10.A-TNP 1310-TNP 45.0 t 2.9 8.9
4 B10 (H-2°) B10 B10 30.7 t 1.2 3.1
1310 (H-2°) 1310-TNP B10 33.8 f 2.9
5 1310 B10 B10-TNP 36.3 t 2.1 11.3
1310 1310-TNP 1310-TNP 47.6 t 2.1
6 B10 1310 B10.A-TNP 41.7 t2.7 3.7
1310 B10-TNP B10.A-TNP 45.4 t3.9
7 B10.BR (H-2°) B10.BR BIO.BR-TNP 41 .0 f 2.0
28.7 B10.13R (H-2k) B10.BR-TNP .B10.BR-TNP 69.7+1 .1
8 B10.BR (H-2k) B10.BR B10.D2-TNP 36.7 f 1.1 1.4
1310.1311 (H-2k) B10.BR-TNP B10.D2-TNP 38.1 t 0.7
9 1310.132 (H-2d) 1310.132 BIO.D2-TNP 30.4 t0.6
1310.132 (H--) B10.D2-TNP 1310.132-TNP 38.0 t 1.4 7.6
10 B10.D2 (H-2j) B10.D2 B10.BR-TNP 46.6 :i= 1.4 -0.9
B10.D2 (H-2d) B10.D2-TNP 1310.1311-TNP 45.7 t 1.5406
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strongly cytotoxic against only TNP-modified B10.A targets and not to H-2-con-
geneic C57BL/10 (H-2°), abbreviated B10, targets (line 2 vs. line 3). Similarly,
B10 cells sensitized to B10-TNP stimulators kill B10-TNP target cells but not
B10.A-TNP targets (line 5 vs. line 6). Further, B10.BR (H-2k) anti-B10.BR-TNP
effector cells are cytotoxic to B10.BR-TNP but not B10.D2-TNP (H--'N) targets
(line 7 vs. line 8). The same wasfound in the reverse direction(line 9 vs. line 10).
In several experiments we have observed a low level of effector cell-induced
cytotoxicity against H-2-unrelated TNP-modified targets (e.g. Table I, line 3).
We interpret this as cross-reactivity between haplotypes of TNP-modified
products controlled by the H-2 complex.
Ability of TNP-Modified Parental Cells to Sensitize Semisyngeneic Re-
sponders to Kill TNP-Modified Parental Targets. While the H-2 complex
restricts the specificity of the cytotoxic effect, the previous experiment does not
distinguish whether the specificity of the killer T cell is directed against an
altered selfH-2 antigen; or alternatively, if the effector andtarget cell must share
a region of the H-2 complex in order for an optimal cytotoxic effect to occur.
Therefore, F, hybrid cells sensitized to irradiated and TNP-modified parental
cells were tested for their cytotoxic potential against the TNP-modified
stimulator cell as well as the other parental cell that was also TNP modified. If
the specificity ofthe effector cell was against an alteredselfH-2 antigen, only the
stimulator cell should be lysed, while both parental targets should be killed if
there is a requirement for sharing of H-2 genes between the effector and target
cell. In Table II is presented the results of one of eight such experiments, all of
which have shown similar findings. (C57BL/6 x DBA-2) (H-2°/H-2d), abbre-
viated BDF,, cells sensitized to DBA/2 (H-2°) TNP-modified stimulators are
cytotoxic against DBA/2-TNP or H-2d tumor target cells, but not against B6
(H-2°) or EL4 (H-2°) targets. When BDF, cells were cocultured with B6-TNP
stimulators, the cytotoxic effect generated was directed against B6-TNP or
EL4-TNP targets, but not against DBA/2-TNP or the H-2d TNP tumor line.
Therefore, sensitization of F, hybrid cells with irradiated TNP-modified paren-
tal cells results in the generation of cytotoxic effector cells that are specific
only for the parental cell to which they are sensitized, and notagainstTNP-modi-
fied targets of the other parent, even though in the latter case the effector and
target cell share the major histocompatibility complex. This indicates that the
specificity of the effector cell in this system is for a modified parental cell sur-
face structure, rather than the specificity of the cytotoxic effect being controlled
by a requirement for sharing of a portion of the major histocompatibility com-
plex between the effector and target cell.
Ability of Unlabeled TNP-Modified Parental Cells to Block the Cytotoxic
Effect of F, Hybrid Cells against TNP-Modified Parental Targets. As further
proofthat the specificity of the receptor on the killer Tcell is directed againstan
altered self cell surface product, we sensitized F, hybrid cells to parental
TNP-modified cells and then attempted to block the specific cytotoxic effect by
adding, along with labeled specific targets, unlabeled TNP-modified Con A
lymphoblasts that either were H-2 compatible with the parental sensitizing
strain, or H-2 incompatible with the sensitizing strain, butH-2 compatible with
the other parental H-2 haplotype ofthe F,. Ifthe receptors on the killer cellshave407
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a broad specificity against several cell surface TNP-modified proteins, and the
role of the H-2 complex in restricting the specificity of the effector cell is by
requiring that the killer and the target cell share a region of the H-2 complex in
order for optimal target cell lysis to occur, then the addition of H-2-allogeneic
unlabeled TNP-modified cells to the cytotoxic assay should block the cytotoxic
effect.
The data in Fig. 1 demonstrates that the (OH x DBA/2)F, (H-2'/H-2d)
hybrid cells sensitized to C3H (H-2'p) TNP-modified stimulators are cytotoxic
to these targets. The reaction is almost completely inhibited by a 50- to 100-fold
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FiG. 1. Percent of "Cr t SEM from 104 TNP-modified C3H Con A lymphoblasts in the
presence of (CM x DBA/2)F, spleen cells sensitized against irradiated C3H-TNP stimulators.
Various numbers of unlabeled TNP-modified Con Alymphoblasts from B10.BR (A), B10.D2
("), or unmodified unlabeled Con A lymphoblasts from B10.BR (A), or Bl0.D2 (0), strain
mice were added along with the labeled targets at the start of the CML assay. ("), immune
release in the absence of unlabeled targets; and (O), nonimmune (control) release in the
absence of unlabeled targets.
excess of unlabeled B10.BR-TNP targets (H-2'p) that are H-2 compatible with
the C3H stimulators. However, B10.D2 (H-2d) TNP cold targets, that share
their H-2 haplotype with the F, hybrid cells but not the C3H stimulators, do
not block. Unmodified cold targets at a 100-fold excess also show no blocking
activity in this system. Thus, in agreement with other previous experiments,
this data shows that the specificity of the effector cell is directed against an
altered selfH-2 antigen.
Ability of Effector Cells Sensitized against TNP-Modified Allogeneic Targets
to Kill TNP-Modified Syngeneic Targets. Another experimental approach to
show that sharing of an H-2-controlled cooperating factor between effector and
target cells is not required for killing of TNP-modified targets was to sensitizeJAMES FORMAN
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cells with allogeneic TNP-modified stimulators and test to see ifthese cells are
cytotoxic against TNP-modified syngeneic targets. B10.D2 (H-2d) cells, sensi-
tized to TNP-modified B10.BR (H-2k) stimulators, were cytotoxic to these
targets but did not kill B10.D2-TNP targets (Table 111; row 2, columns 4 and 2).
The same result was observed when B10.BR cells, sensitized to B10.D2-TNP
stimulators, were tested against B10.BR-TNP targets (Table III; row 3, column
2). Thus, even though the effector and target cell are identical, TNP-modified
target cells are not killed, which further indicates that sensitization by
TNP-modified cells involves the presentation of an altered self H-2 antigenic
determinant.
TABLE III
Ability ofEffector Cells Sensitized against TNP-Modified H-2Allogeneic Stimulators to
Display a Cytotoxic Effect against TNP-Modified Targets Syngeneic with the
Effector Cells
% "Cr Release t SEM
(34.6) (37.2)
￿
(8.2)
*Column number/see text.
fNonimmune control groups.
§Net release, % "Cr release from targets in the presence of immune cells - % "Cr Reease from
targets in the presence of nonimmune cells (see footnote $).
Ability of F, Hybrid Spleen Cells Sensitized to Parental TNP-Modified Cells
to Display a Cytotoxic Effect against TNP-Modified F, Targets. To demon-
strate that products controlled by the H-2 complex are altered in a similar man-
ner on parental as well as F, hybrid cells, we sensitized F, cells against
parental TNP stimulators and then tested the effector cells against TNP-modi-
fied parental and F, hybrid targets. The data in Table IV show that H-2'-con-
trolled products are altered in a similar manner on both parental and F, cells be-
cause (AKR x DBA-2)F,, abbreviated AKD2F, cells, (H-2k/H-2d) sensitized to
AKR-TNP-irradiated stimulators, are cytotoxic to these targets as well as
AKD2F,-TNP targets. As found in other experiments, DBA/2-TNP (H-2d) tar-
getsarenotlysed.
Ability of F, Hybrid Cells to Display a Cytotoxic Effect against TNP-Modified
Parental Cells as well as other Targets that Share either the K or D End of the
Row Responder Target
BlO.D2
(1*)
Stimulator:
B10.D2-TNP B10.BR
(2) (3)
B10.BR-TNP
(4)
1 B10.D2 B10.D2-TNP 35.4 t 1.4$ 49.1 f 1.9 45.0 t 3.3 45.1 4:0.6
(13.7)§ (9.6) (9.7)
2 BlO.D2 B10.BR-TNP 34.4 t 0.7$ 41 .3 t 2.0 79.7 t 0.8 76.6 t 2.3
(6.9) (45.3) (42.2)
3 B10.BR B10.BR-TNP 48.7 t 1.5 45.4 f 1.2 38.5 t 2.3$ 76.2 f 2.8
(10.2) (6.9) (37.7)
4 B10.BR B10.D2-TNP 69.6 t 2.5 72.2 :i= 2.5 35.0 :i= 1.7$ 43.2 t 1.4410
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TABLE IV
Ability of F, Hybrid Spleen Cells Sensitized to Parental TNP-Modified Cells to Displaya
Cytotoxic Effect against TNP-Modified F, Target Cells
*See Table I for explanation.
H-2 Complex with the Stimulator. H-2-recombinant strains were tested in
order to determinewhether theKorD end ofthe H-2complex controlled the gene
products altered by the TNBS. AKD2F, cells (H-2k/H-2d), sensitized to AKR
(H-2k) TNP-modified cells were cytotoxic against AKR-TNP targets, but not
against DBA/2-TNP (H-2d) targets (Table V). When tested against an H-2-
unrelated target, B10 (H-26), a weakeffect wasobserved, similarto that shown in
the experiment presented in Table 1. When TNP-modified AM (H-2a) cells, a
strain which is an H-2 recombinant that shares the K end of the H-2 complex
with H-2k (4) were tested as targets, a strong cytotoxic effect wasobserved. Thus,
the data showsthat identity at the K end ofthe H-2 complex with the sensitizing
strain will leadtoCML in this system, similar to that observed by Shearer (1).
When DBA/2-TNP stimulators were used, DBA/2-TNP targets were killed
while AKR-TNP targets were not. Again, there was a weak reactivity against
B10-TNP targets. A/J-TNP targets, that in this case share the D end of the H-2
complex with the DBA/2 (H-2d) haplotype were also killed, but to a much lesser
extent than when AKR-TNP cells were the stimulators. To demonstrate that
TNP-modified 1310 cells can be killed, we sensitized 1310 spleen cells against
B10-TNP targets and showed that such targets were lysed.
In Table VI the protocol was the same asfor the experiment shown in Table V,
except that weusedH-2-congenic lines for target cells in ordertodetermine ifthe
specificity was in fact controlled by the H-2-gene complex. The results here
confirm the data of the experiment presented in Table V, and show that the
requirement for positive CML in this system is controlled by the H-2 complex. It
was also noted that when DBA/2-TNP cells were the stimulators, the cytotoxic
effect was much less than when AKR-TNP cells were the stimulators, a result
that has been frequently observed in other experiments as well. Thus, the fact
that BIO.A-TNP targets were not killed by the AKD2F, anti-DBA/2 TNP
effectors in this experiment may have been due to the weak cytotoxic effect that
was generated.
Responder Stimulator Target 5'Cr release
f SEM
Net
release*
(AKR x DBA/2)F, AKR AKR-TNP 42.3 t 5.5
(AKR x DBA/2)F, AKR-TNP AKR-TNP 76.4 t 3.0 34.1
(AKR x DBA/2)F, AKR DBA/2-TNP 44.7 t 1.9
(AKR x DBA/2)F, AKR-TNP DBA/2-TNP 45.6f 1.0 0.9
(AKR x DBA/2)F, AKR (AKR x DBA/2)F,- 30.6 f 3.4
TNP 30.8 (AKR x DBA/2)F, AKR-TNP (AKR x DBA/2)F,- 61.4 t 0.5
TNPTABLE V
Ability ofF, Hybrid Spleen Cells, Sensitized to Irradiated and TNP-Modified Parental
Cells, toDisplay a CytotoxicEffect against TNP-Modified Targets that areH-2Related to
the Stimulator
(17.4)
*Net release, see Table I for explanation.
TABLE VI
Ability ofF, Hybrid Spleen Cells, Sensitized to Irradiated and TNP-Modified Parental
Cells, to Display a Cytotoxic Effect against TNP-Modified H-2 Congenic Targets
* Net release, see Table I for explanation.
JAMES FORMAN
"Cr release t SEM
I'Cr release t SEM
Target (genotype) :
Region of the H-2 Complex that Controls the Cell Surface Product being
Modified by TNBS. Whileour previous data show thatboth the KandDend of
the H-2complex control theexpression ofthe altered cell surface antigens, it does
not distinguish the role of the individual K, D, and I regions. Therefore,
experiments were done using H-2-recombinant strains toresolve the rule ofthese
individual regions. In Table VII a representative experiment is presented where
B10.BR (kkkk) (gene symbols refer to the K, I, S, and D regions of the H-2
Responder
(genotype)
Stimulator
(genotype)
AKR-TNP
(H-2k)
Target (genotype):
DBA/2-TNP B10-TNP
(H-2°) (H-2")
A/J-TNP
(H-2°)
(AKR x DBA/2)F, AKR (H-2k) 35.9 t 1.4 39.3 t 3.6 46.0 t 0.8 45.8 t 0.9
(H-2*IH-2°)
(AKR x DBA/2)F, AKR-TNP 69.3 t 1.5 38.3 t 0.8 53.6 t 1.2 74.6 t 4.9
(H-2kIH-2°) (33.4)* (-1.0) (7.6) (28.8)
(AKR x DBA/2)F, DBA/2 (H-2°) 40.3 t 7.9 43.0 t 1.6 43.2 t 2.6 49.6 t 3.6
(H-2"IH-2°)
(AKR x DBA/2)F, DBA/2-TNP 39.3 t 1.3 58.9 t 2.4 48.5 t 2.6 59.4 t 2.3
(H-2k1H-2°) (-1.0) (15.9) (5.4) (9.8)
1310 (H-2°) B10 (H-2) 45.6 1.7
B10 (H-2) B10-TNP 63.0 t 0.9
Responder
(genotype)
Stimulator
(genotype) BlO.BR-TNP
(H-2k)
BIO.D2-TNP
(H-2°)
BlOTNP
(H-2)
BlO.A-TNP
(H-2°)
(AKR x DBA/2)F, AKR (H-2") 37.0 t 1.5 32.5 -±:2.6 39.1 t 0.8 42.7 t 2.3
(H-2klH-2°)
(AKR x DBA/2)F, AKR-TNP 53.1 t 0.6 32.0 .i= 0.6 39.4 t 2.0 60.5 t 2.1
(H-2"IH-2°) (16.1)* (-0.5) (0.3) (17.8)
(AKR x DBA/2)F, DBA/2 (H-2') 36.4 t 2.9 34.1 t 1.9 39.5 t 1.6 43.6 t 2.6
(H-2*IH-2°)
(AKR x DBA/2)F, DBA-TNP 37.6 :i= 2.6 40.8 t 1.6 40.6 t 2.2 42.8 t 0.9
(H-2kIH-2) (1.2) (6.7) (1.1) (-0.8)412
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TABLE VII
Role of H-2 Regions in Determining Cytotoxicity against TNP-Modified Targets
Stimulator
(genotype)
B10.BR
(kkkk)* t
BlO.BR-
TNP
(kkkk)
B10.BR-TNP 34.8 t 3.8 71.6 f 0.5
(kkkk) I
￿
I (36.8)
B10.AQR
(qkdd)
40.9 t 4.0
"Cr release f SEM
Target cell (genotype):
B10.AQR-
TNP
(qkdd)
36.0 t 0.4
(-4.9)
B10.A
(kkdd)
27.0 f 3.7
B10.A-
TNP
(kkdd)
%
67.7 f 2.2
(40.7)
C3H.OH
(dddk)
%
27.9 f 0.4
Responder
(genotype)
B10.BR
(kkkk)
* Gene symbols refer to the K, I, S, and D regions of the H-2 complex.
#Underlined gene symbol denotes sharing of region between stimulator and target cell.
C3H.OH-
TNP
(dddk)
%
40.7 t 2.1
(12.8)
complex) effector cells, sensitized to B10.BR-TNP-modified targets were cyto-
toxic to R10.BR, B10.A (kkdd), AND C3H.OH (dddk), but not B10. AQR (gkdd)
TNP-modified targets. In Table VIII all of the mapping data, using several other
recombinant strains, are summarized. The results show that if a target shares the
K and I region of the H-2 complex with the stimulator, CML results, while if the I
region only is shared, the result is negative. When only the D region of the H-2
complex is shared with the specific target, an isotope release of greater than 10%
was observed in only half of the experiments. Further, in these cases the cytotoxic
effect was much less than that observed against the specific target cells. We
conclude that if the Dregion of the H-2 complex is involved, it is to a much lesser
degree than that of the H-2K region.
Discussion
There is a large body of evidence demonstrating that cytotoxic effector T cells
are generated both in vivo and in vitro in H-2-allogeneic combinations and the
cytotoxic effect that is observed is specific for either targets of the sensitizing
strain or H-2-recombinant strains that share either their K or D end with the
sensitizing strain (5, 6). In fact, the strongest CML reponses are demonstrated in
allogeneic combinations, while generally it has been difficult to demonstrate
syngeneic cytotoxicity; e.g., tumor immune systems (7, 8) .
The evidence in this study as well as other reports, where the cytotoxic effect
has been directed against determinants other than H-2 antigens, indicates that
for the expression of T-cell-mediated cytotoxicity, there is a restriction in that
the effector and target cell must share the major histocompatibility complex.
Thus, I observed that spleen cells, sensitized to TNP-modified syngeneic splenic
stimulators, display a cytotoxic effect against only TNP-modified targets that are
H-2 compatible with the stimulator. Similar results have been found by Shearer
(1) and by Koren et al. (9) using a different hapten. In a viral system, it has been
demonstrated that the host response to lymphocytic choriomenigitic virus (LCM)
in vivo results in the generation of effector cells that are cytotoxic in vitro
against only H-2-compatible LCM-infected targets (10) . In another model, Ilfeld
et al. (11) have shown that spleen cells sensitized to syngeneic fibroblasts in vi-
tro generate cytotoxic effector cells against syngeneic or H-2-compatible fibro-
blasts whereas H-2-incompatible fibroblasts are not killed.TABLE VIII
Summary of CML Reactivity of Effector Cells against TNP-Modified H-2-Recombinant
Target Cells
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*Refers to K, I, S, and D regions of H-2 complex.
fOne experiment.
§Three experiments.
11 One experiment.
1f + indicates net release of I'Cr >_ 10%.
**Indicates H-2 regions shared by stimulator (oreffector) cell and target.
$$ Not tested.
§§ Net release <10%.
While the role of the H-2 complex in restricting the specificity of the cytotoxic
effect in these experiments could be explained by a cooperation model which
would require effector and target cell to share some H-2-gene products in order
for an optimal cell-to-cell interaction, the data in this studyshow that this is not
the case for the TNP-modification system; rather, the specificity of the effector
cell is directed against an altered self cell surface product controlled by the H-2
complex. Thus, F, hybrid cells sensitized to a TNP-modified parental strain cell
displayed a cytotoxic effect against only that TNP-modified parental target and
not against TNP-modified cells from the other parent even though one haplotype
of the effector cell in this latter case shared the H-2 complex with the target.
Further, F, hybrid cells sensitized to parental TNP-modified cells were blocked
from killing these parental targets by unlabeled TNP-modified targets H-2
compatible with the parental strain used for sensitization, but not with cold
TNP-modified targets that were H-2 syngeneic with the other parental strain .
This finding shows that the specificity ofthe receptor on the killer cell is specific
for a particular TNP-modified H-2-controlled-gene product. Moreover, I ob-
served that cells of one strain, sensitized to TNP-modified H-2-allogeneic strain
cells, did not kill TNP-modified targets that were syngeneic to the effector cells,
which should have occurred if the cooperation model were correct, since the
effector and target cell in this case are H-2 identical.
Another possible interpretation of this data is that there is allelic exclusion of a
cooperating factor controlled by the H-2 complex. Thus, only F, cells expressing a
product in common with one of the modified parental cells would be sensitized, and these
TNP-modified target
cell (genotype)*
Cytotoxic effect of responder
shared by target cell
B10.BRanti-
1310.13R-TNP$
antistimulator
andstimulator
1310.A anti-
B10.A-TNP§
cells (denotes H-2 region
foreffector] cell)
1310 anti-
1310-TNPII
B10.BR (kkkk) +1f (K I SD)** + (K I--) NT
B10.D2 (dddd) NT$$ -§§ (-ISD) NT
B10.A (kkdd) + (K I- -) + (K 1S D) - (- - - -)
B10 (bbbb) NT - (----) + (K IS D)
B10.AQR (qkdd) - (-I--) NT NT
C3H.OH (ddkk) + (- - -D) NT NT
B10.S (7R) (sssd) NT - (---D) NT
B10.A (4R) (kkbb) NT + (K I --) + (-ISD)
B10.BYR (gkdb) NT - (-IS-) - (--- D)414
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sensitized cells would not be able to interact with modified cells from the other parental
haplotype. Since there is no evidence for allelic exclusion in the H-2 complex where both
gene products are expressed in a codominant fashion (12) this interpretation is unlikely.
By employing H-2-recombinant mouse strains, we ascertained that a cytotoxic effect
was observed against TNP-modified target cells that shared their K region with the
stimulator strain, since those targets that shared only the Iregion were not killed. Strains
that shared only their D region with the stimulator were lysed in the assay, but the
amount of lysiswas much less that if the K region were shared, and I conclude, therefore,
that if the D region is involved in this phenomenon, then it is to a much lesser extent than
the K region. Thus, the findings here contrast with the role of the H-2 complex in the
immune response to antigens under Ir-gene control, which requires sharing of the I region
between responder T and B cells for an optimal response (13). Similar results have been
observed in another system by Blanden et al. (14), in which they showed that cytotoxic T
cells sensitized against LCM-infected cells must share the Kor D, but not I, region of the
H-2 complex with the target cell in order for lysis to occur. Further, it was demonstrated
(15) that LCM sensitized F, (H-2k/H-2°) cells transferred in vivo to H-21 recipients will
retain cytotoxic activity against H-2k LCM-infected targets in vitro, while transfer to
recipients bearing other H-2 haplotypes will not.
The findings in this study demonstrate that syngeneic killing is analogous to
classical allogeneic cytotoxicity, since the effector cells in this syngeneic system
are in reality sensitized to H-2-gene products (in this case a modified self H-2
antigen), and further suggest that some H-2-gene products may play an
obligatory role in bringing about target cell lysis by effector T cells. Speculations
on the possible mechanisms underlying this type of cell-mediated cytotoxicity
are diagrammatically illustrated in Fig. 2 . Here it is postulated that H-2-gene
products are linked to an enzyme(s) on the cell surface, or have intrinsic
enzymatic activity that readily allows the destruction of the target cell when
interaction occurs with the receptor on a cytotoxic T cell (Fig. 2 A and B) .
Alternatively, the interaction of this gene product with the receptor on the T cell
B
C
FIG. 2.
￿
(y, H-2-controlled product; T, cytotoxic T cell; and t, target cell. Interaction of the
receptor on a cytotoxic T cell with an H-2-controlled product leads to A, activationof intrinsic
H-2 enzymatic activity, or B, activationof an enzyme (e) coupled on the cell surface to the H-2
product. The activated enzyme causes the formation of lytic lesions in the cell membrane. C,
interaction of the receptor on a cytotoxic T cell with an H-2-controlled product leads to the
transmission of a substance from the killer cell to the target cell cytoplasm . The substance acts
as an intracellular toxin causing target cell death.JAMES FORMAN
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could result in the transmission of an active fragment from the killer cell into the
target cell cytoplasm which inhibits macromolecular synthesis, analogous to the
action of diphtheria toxin (Fig. 2 C) (16). Here, the altered target cell
permeability that isobserved would be a secondary effect. Ifthis model is correct,
then in the TNP system one would expect many clones ofT cells tobe sensitized
to several different TNP-modified cell surface proteins, but the only modified
determinant that would result in effective or optimal target cell lysis by
interaction with a reactive T cell is that associated with an H-2 product. If H-2
antigens arerequired on the target cell forthe expression ofT-cell-mediated lysis
against cell surface antigens in general, then phenotypic H-2-negative cells
should be resistant to T-cell-mediated cytolysis. We have reported such a finding
using a 129 strain primitive teratocarcinoma cell line, F9, that is H-2 negative
both by serological and CML analysis (17, 18). When we modified this F9 tumor
line with TNP, we found that it is not killed by 129 anti-129 TNP effector cells
while 129-TNP-modified spleen cells were (18).
There is some structural similarity (19) and considerable cross-reactivity at the
antibody level between products of different H-2 haplotypes, as well as between
products of the Kand D regions (20, 21). We have observed that the majority of
iodinatable cell surface protein is derivatized by TNP in this coupling procedure
(E. S. Vitetta, unpublished observations). Therefore, it is difficult at this time to
understand the basis for the specificity of this response. One explanation is that
the serologically characterized H-2Kglycoproteinsarenot the products modified,
but rather another product, different between haplotypes and closely linked to
H-2K, is the modified target antigen for this reaction. While there is some
evidence in support of this interpretation (22-24), the absence ofrecombinants in
mouse or man that separate these two postulated products makes this possi-
bility unlikely.
Itis presentlynot possible to distinguish whether the reaction ofTNBS on theH-2-gene
product itself is the critical step in creating the NAD, or whether another cell surface
protein, that is also TNP modified, then associates with H-2 antigens in a complex to
create theNAD. In other systems there isevidence to suggestaphysical associationon the
cell surface of H-2 products with viral-specified antigens. For example, Aoki (25) has
observed that viral budding particles from Gross virus-induced leukemias are associated
with H-2 antigens in H-21-infected cells, but not in H-2°-infected cells. Hecht and
Summers (26) have observed H-2 activity in vesicular stomatitis virus particles released
from L cells. Fujimoto et al. (27) have found a physical association of histocompatibility
antigens with tumor-associated antigens in the sera of mice bearing a spontaneous
lymphoma. Rossi et al. (28) found that while DBA/2 bone marrow cells were notrejected
by semisyngeneicrecipients, Friend leukemia virus-treated bone marrow cells were. They
interpreted thisfinding to an enhancement of the expression ofhybrid histocompatibility
genes in these parental cells which allow the F, hybrid to exhibit "hybrid resistance" (29).
However, creation ofa NAD on the parental cell consisting ofselfH-2 antigens andFriend
leukemia virus is another possibility.
In summary, I have provided evidence to show that modification ofcells with
TNBS results in altered cell surface antigens controlled principally by the K
region of the H-2 complex, and the specificity of the killer cell generated in in
vitro culture systems is directed against this altered H-2-gene product. I suggest416
￿
ROLE OF THE H-2 COMPLEX IN SYNGENEIC CML
that H-2K- and D-controlled antigens may play an obligatory role in cell-
mediated lysis by T cells.
Summary
Spleen cells cultured with syngeneic trinitrophenyl (TNP)-modified stimula-
tor cells display a cytotoxic effect against syngeneic TNP-modified targets, but
not against modified targets from unrelated H-2 haplotypes. Targets that share
the K and I region of the H-2 complex with the stimulator (or effector) cell are
lysed to the same extent as the specific targets, while targets that share the I
region only are not. When only the D region is shared, a weak cytotoxic effect is
observed . Therefore, the stimulator (or effector) and target cell must share theK
or D but not the I region of the H-2 complex in order for optimal cytotoxicity to
occur.
Spleen cells sensitized to irradiated TNP-modified H-2-allogeneic cells are
cytotoxic to these specific targets, but not against TNP-modified targets
syngeneic with the effector cells. Coculture of F, hybrid cells with irradiated
TNP-modified parental cells results in a cytotoxic effect against only those
specific parental cells and not TNP-modified cells from the other parent. The
cytotoxic effect of the F, effector cells in the cell-mediated lympholysis test is
blocked by the addition of unlabeled TNP-modified targets that are H-2
syngeneic with the sensitizing parental strain, but not H-2 syngeneic with the
other parental strain. These data demonstrate that the specificity of the effector
cell in this syngeneic cytotoxicity system is directed against altered self
H-2-controlled-gene products, rather than a requirement for sharing of
histocompatibility genes between effector and target cell in order for lysis to
occur. The role of H-2 antigens in determining the sensitivity of a target cell to
T-cell-mediated lysis is discussed.
I thank Doctors Jonathan W. Uhr andJan Klein for theirhelpful criticisms of this work, and Arthur
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